Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 15, 2022. Long positions only.
- Positions
- 4
- No filing for Q3 2021
- Portfolio value
- $285.7M
- No filing for Q3 2021
Northpond Ventures, LLC did not file a 13F for Q3 2021, so these holdings cannot be compared with the previous quarter and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $106.3M | 37.2% | – | – | History |
| DICEDICE Therapeutics, Inc. | COM | 3,292,871 | $83.3M | 29.2% | – | – | History |
| ISOIsoPlexis Corp | COM | 8,805,272 | $80.9M | 28.3% | – | – | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $15.1M | 5.3% | – | – | History |